Tag: Professor Yohann Loriot
Antibody–drug conjugate shows signs of efficacy in advanced cervical cancer
Professor Yohann Loriot, deputy head of the department of therapeutic innovation and early phase trials (DITEP) at Gustave Roussy, presented at the ASCO congress...